☆ 4.5 Article

The role of Lamin A/C mutations in Danish patients with idiopathic dilated cardiomyopathy

EUROPEAN JOURNAL OF HEART FAILURE (2009)

Journal

EUROPEAN JOURNAL OF HEART FAILURE

Volume 11, Issue 11, Pages 1031-1035

Publisher

WILEY

DOI: 10.1093/eurjhf/hfp134

Keywords

-

Categories

Cardiac & Cardiovascular Systems

Funding

Danish Heart Foundation [07-10-R60-A1826-B323-22423]
Edith and Olfert Dines Hansen Foundation
John and Birthe Meyer Foundation

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper

Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5

Not enough ratings

Secondary Ratings

Novelty

-

Significance

-

Scientific rigor

-

Rate this paper

Recommended

Article Oncology

DNA methylation analysis reveals epimutation hotspots in patients with dilated cardiomyopathy-associated laminopathies

Julien L. P. Morival, Halida P. Widyastuti, Cecilia H. H. Nguyen, Michael Zaragoza, Timothy L. Downing

Summary: The study found family-specific DMRs in fibroblasts caused by LMNA mutations associated with dilated cardiomyopathy (DCM), linked to genes related to laminopathy phenotypes. Inter-family epimutation hotspots near differentially expressed genes found outside LADs redistributed in LMNA-related DCM were identified. Comparison of DMRs in fibroblasts and iPSCs revealed persistent epimutations across both cell types.

CLINICAL EPIGENETICS (2021)

Add to Collection

Article Genetics & Heredity

Circulating circRNA as biomarkers for dilated cardiomyopathy etiology

Marina C. Costa, Maria Calderon-Dominguez, Alipio Mangas, Oscar Campuzano, Georgia Sarquella-Brugada, Monica Ramos, Maribel Quezada-Feijoo, Jose Manuel Garcia Pinilla, Ainhoa Robles-Mezcua, Galan del Aguila Pacheco-Cruz, Thalia Belmonte, Francisco J. Enguita, Rocio Toro

Summary: Peripheral circRNAs show potential as non-invasive biomarkers for etiology-based diagnosis of dilated cardiomyopathy, with the ability to differentiate between different causes of DCM and correlate with echocardiographic parameters.

JOURNAL OF MOLECULAR MEDICINE-JMM (2021)

Add to Collection

Article Cardiac & Cardiovascular Systems

The LMNA p.R541C mutation causes dilated cardiomyopathy in human and mice

Luzi Yang, Jinhuan Sun, Zhan Chen, Lei Liu, Yueshen Sun, Junsen Lin, Xiaomin Hu, Mingming Zhao, Yuanwu Ma, Dan Lu, Yifei Li, Yuxuan Guo, Erdan Dong

Summary: The LMNA c.1621C > T/ p.R541C variant contributes to dilated cardiomyopathy (DCM) by enhancing heterochromatic gene suppression and disrupting mitochondrial functions.

INTERNATIONAL JOURNAL OF CARDIOLOGY (2022)

Add to Collection

Article Cardiac & Cardiovascular Systems

A very long-term observation of a family with dilated cardiomyopathy and overlapping phenotype from lamin A/C mutation

Maurizio Porcu, Marco Corda, Daniele Pasqualucci, Giulio Binaghi, Nadia Sanna, Gildo Matta, Stefano Cossa, Antonio Scalone, Gianfranco Tola

Summary: This study describes a case of a whole family affected by a lamin A/C gene mutation over a longitudinal follow-up of more than 22 years. The overlapping phenotype with cardiac and extracardiac involvement was observed, with cardiac alterations associated with lipodystrophy and neurological manifestations over time. Early detection of cardiac alterations through cardiac magnetic resonance and right bundle branch block as a sign of initial phenotypical expression were highlighted.

JOURNAL OF CARDIOVASCULAR MEDICINE (2021)

Add to Collection

Article Biochemistry & Molecular Biology

Early onset atrial lesions in a patient with a novel LMNA frameshift mutation

Yongping Lin, Hailei Liu, Chang Cui, Zhiqiao Lin, Yike Zhang, Yue Zhu, Weizhu Ju, Minglong Chen

Summary: A novel frameshift mutation (p.P485Tfs*67) in the LMNA gene was identified in a patient with early-onset atrial disease. A transgenic zebrafish model confirmed the pathogenicity of this mutation, showing abnormal ECG and impaired myocardial structure in adult zebrafish, suggesting the atrial pathogenicity of the LMNA-P485Tfs mutation and providing insights into the function of the Ig-like domain of lamin A/C.

HUMAN MOLECULAR GENETICS (2021)

Add to Collection

Article Medicine, Research & Experimental

Genetic analysis using targeted next-generation sequencing of sporadic Chinese patients with idiopathic dilated cardiomyopathy

Mingmin Li, Shuang Xia, Lan Xu, Hong Tan, Junqing Yang, Zejia Wu, Xuyu He, Liwen Li

Summary: Using targeted next-generation sequencing, potential genetic causes of idiopathic DCM were identified. Sarcomere mutations remained the most common genetic cause of inherited DCM in this cohort of sporadic Chinese DCM.

JOURNAL OF TRANSLATIONAL MEDICINE (2021)

Add to Collection

Article Cardiac & Cardiovascular Systems

Cardiomyocyte Proliferative Capacity Is Restricted in Mice With Lmna Mutation

Kenji Onoue, Hiroko Wakimoto, Jiangming Jiang, Michael Parfenov, Steven DePalma, David Conner, Joshua Gorham, David McKean, Jonathan G. Seidman, Christine E. Seidman, Yoshihiko Saito

Summary: The mutation of LMNA gene contributes to the development of DCM by impairing cell proliferation capacity and cell cycle defects, which is distinct from the mechanisms of other causative genes of DCM.

FRONTIERS IN CARDIOVASCULAR MEDICINE (2021)

Add to Collection

Article Medicine, Research & Experimental

Systematic in vivo candidate evaluation uncovers therapeutic targets for LMNA dilated cardiomyopathy and risk of Lamin A toxicity

Chia Yee Tan, Pui Shi Chan, Hansen Tan, Sung Wei Tan, Chang Jie Mick Lee, Jiong-Wei Wang, Shu Ye, Hendrikje Werner, Ying Jie Loh, Yin Loon Lee, Matthew Ackers-Johnson, Roger S. Y. Foo, Jianming Jiang

Summary: In this study, the authors evaluated 14 potential candidates, including Lmna gene products, key signaling pathways, calcium handling, proliferation regulators, and modifiers of LINC complex function, in a specific Lmna DCM model. They found that several candidates, including Smad3, Yy1, Bmp7, Ctgf, aYAP1, Sun1, Lamin A, and Lamin C, restored cardiac function and reduced markers of heart failure and fibrosis in Lmna DCM. Knockdown of Sun1 or supplementation of Lamin C also led to prolonged survival. However, supplementation of Lamin A did not improve long term survival and could even induce DCM in healthy hearts. These findings suggest that Lamin C and Sun1 may be potential therapeutic targets for LMNA DCM.

JOURNAL OF TRANSLATIONAL MEDICINE (2023)

Add to Collection

Article Cardiac & Cardiovascular Systems

Mortality Among Patients With Early-Onset Atrial Fibrillation and Rare Variants in Cardiomyopathy and Arrhythmia Genes

Zachary T. Yoneda, Katherine C. Anderson, Fei Ye, Joseph A. Quintana, Matthew J. O'Neill, Richard A. Sims, Lili Sun, Andrew M. Glazer, Giovanni Davogustto, Majd El-Harasis, James L. Laws, Brittany N. Saldivar, Diane M. Crawford, Thomas Stricker, Quinn Wells, Dawood Darbar, Gregory F. Michaud, Lynne W. Stevenson, Steven A. Lubitz, Patrick T. Ellinor, Dan M. Roden, M. Benjamin Shoemaker

Summary: This study assessed the association between rare variants in cardiomyopathy and arrhythmia genes and time to death in patients with early-onset atrial fibrillation (AF). The findings suggest that disease-associated variants may be associated with increased mortality risk, especially in those diagnosed at a younger age.

JAMA CARDIOLOGY (2022)

Add to Collection

Article Cardiac & Cardiovascular Systems

The response to cardiac resynchronization therapy in LMNA cardiomyopathy

Kiran Sidhu, Anna Isotta Castrini, Victoria Parikh, Nosheen Reza, Anjali Owens, Maxime Tremblay-Gravel, Matthew T. Wheeler, Luisa Mestroni, Matthew Taylor, Sharon Graw, Marta Gigli, Marco Merlo, Alessia Paldino, Gianfranco Sinagra, Daniel P. Judge, Hannia Ramos, Olurotimi Mesubi, Emily Brown, Samual Turnbull, Saurabh Kumar, Darius Roy, Usha B. Tedrow, Long Ngo, Kristina Haugaa, Neal K. Lakdawala

Summary: Cardiac resynchronization therapy (CRT) plays an important role in improving heart failure in LMNA cardiomyopathy patients, especially in those with strong guideline indications. The study found that patients who responded to CRT had improved systolic function and experienced survival benefits.

EUROPEAN JOURNAL OF HEART FAILURE (2022)

Add to Collection

Article Multidisciplinary Sciences

Cardiac mitofusin-1 is reduced in non-responding patients with idiopathic dilated cardiomyopathy

Yung Ting Hsiao, Ippei Shimizu, Takayuki Wakasugi, Yohko Yoshida, Ryutaro Ikegami, Yuka Hayashi, Masayoshi Suda, Goro Katsuumi, Masaaki Nakao, Takuya Ozawa, Daisuke Izumi, Takeshi Kashimura, Kazuyuki Ozaki, Tomoyoshi Soga, Tohru Minamino

Summary: Prognosis of severe heart failure remains poor and urgent new therapies are required. Some heart failure patients, classified as non-responders, show significantly reduced levels of the mitochondrial fusion protein Mfn1. This study reveals that Mfn1 may serve as a biomarker for heart failure in non-responders, with potential therapeutic targeting of mitochondrial dynamics to improve outcomes.

SCIENTIFIC REPORTS (2021)

Add to Collection

Article Medicine, General & Internal

Cardiovascular Magnetic Resonance in Peripartum Cardiomyopathy: Comparison with Idiopathic Dilated Cardiomyopathy

Joanna Petryka-Mazurkiewicz, Karolina Kryczka, Lukasz Mazurkiewicz, Barbara Milosz-Wieczorek, Mateusz Spiewak, Magdalena Marczak, Jan Henzel, Jacek Grzybowski, Marcin Demkow, Zofia Dzielinska

Summary: Using cardiovascular magnetic resonance (CMR) imaging, subtle differences were found between peripartum cardiomyopathy (PPCM) and dilated cardiomyopathy (DCM), with the main variations being observed in the performance of the right atrium (RA) and left ventricular (LV) global longitudinal strain.

DIAGNOSTICS (2021)

Add to Collection

Article Medicine, General & Internal

Clinical Features of LMNA-Related Cardiomyopathy in 18 Patients and Characterization of Two Novel Variants

Valentina Ferradini, Joseph Cosma, Fabiana Romeo, Claudia De Masi, Michela Murdocca, Paola Spitalieri, Sara Mannucci, Giovanni Parlapiano, Francesca Di Lorenzo, Annamaria Martino, Francesco Fedele, Leonardo Calo, Giuseppe Novelli, Federica Sangiuolo, Ruggiero Mango

Summary: LMNA gene mutations account for familial dilated cardiomyopathy, which presents with a variety of symptoms and can lead to sudden cardiac death. Genetic testing and phenotype correlation studies help further understand the disease. Research findings suggest that LMNA variants significantly affect nuclear morphology and lamin expression.

JOURNAL OF CLINICAL MEDICINE (2021)

Add to Collection

Review Medicine, General & Internal

Cardiac Filaminopathies: Illuminating the Divergent Role of Filamin C Mutations in Human Cardiomyopathy

Matthias Eden, Norbert Frey

Summary: Recent advances in understanding genetic alterations in various genes have shed light on the complex nature of cardiac diseases, potentially aiding in identifying high-risk patients and developing personalized therapies.

JOURNAL OF CLINICAL MEDICINE (2021)

Add to Collection

Article Cardiac & Cardiovascular Systems

Prognostic value of multiple cardiac magnetic resonance imaging parameters in patients with idiopathic dilated cardiomyopathy

Hang Fu, Lingyi Wen, Huayan Xu, Hui Liu, Rong Xu, Linjun Xie, Ran Sun, Kun Zhang, Lu Zhang, Zhigang Yang, Yingkun Guo

Summary: The study found that NT-proBNP and extent of LGE were reliable predictors in IDCM patients with reduced LVEF. Additionally, the presence of LGE combined with NT-proBNP showed the strongest prognostic value in this patient population, while myocardial strain parameters seemed to have no prognostic value.

INTERNATIONAL JOURNAL OF CARDIOLOGY (2021)

Add to Collection

Article Cardiac & Cardiovascular Systems

The left atrial appendage closure by surgery-2 (LAACS-2) trial protocol rationale and design of a randomized multicenter trial investigating if left atrial appendage closure prevents stroke in patients undergoing open-heart surgery irrespective of preoperative atrial fibrillation status and stroke risk

Christoffer Laessoe Madsen, Jesper Park-Hansen, Akhmadjon Irmukhamedov, Christian Lildal Carranza, Sulman Rafiq, Rafael Rodriguez-Lecoq, Neiser Palmer-Camino, Ivy Susanne Modrau, Emma C. Hansson, Anders Jeppsson, Rakin Hadad, Angel Moya-Mitjans, Anders Moller Greve, Robin Christensen, Helle Gervig Carstensen, Nis Baun Host, Ulrik Dixen, Christian Torp-Pedersen, Lars Kober, Ismail Gogenur, Thomas Clement Truelsen, Christina Kruuse, Ahmad Sajadieh, Helena Dominguez

Summary: This study aims to investigate the effectiveness of IAA closure during open-heart surgery in preventing thromboembolisms in patients with atrial fibrillation. The randomized multicenter trial includes patients from Denmark, Spain, and Sweden and is likely to influence the use of left atrial appendage closure in open-heart surgery.

AMERICAN HEART JOURNAL (2023)

Add to Collection

Letter Cardiac & Cardiovascular Systems

Transforming Growth Factor-β Analysis of the VANISH Trial Cohort

Yuri Kim, Mitra E. Mastali, Jennifer Van Eyk, E. John R. Orav, Christoffer M. Vissing, Sharlene Day, Anna Axelsson W. Raja, Mark Russell, Kenneth M. Zahka, Harry C. Lever, Alexandre M. Pereira, Anne Murphy, Charles G. Canter, Richard T. Bach, Matthew W. Wheeler, Joseph T. Rossano, Anjali Owens, Henning Bundgaard, Lee Benson, Luisa Mestroni, Matthew R. G. R. Taylor, Amit Patel, Ivan Wilmot, Philip H. Thrush, Jonathan R. Soslow, Jason E. Becker, Christine Y. Seidman, Carolyn Ho

CIRCULATION-HEART FAILURE (2023)

Add to Collection

Article Cardiac & Cardiovascular Systems

Severity of Brugada syndrome disease manifestation and risk of new-onset depression or anxiety: a Danish nationwide study

Camilla H. B. Jespersen, Johanna Kroll, Priya Bhardwaj, Bo Gregers Winkel, Peter Karl Jacobsen, Christian Jons, Jens Haarbo, Jens Kristensen, Jens Brock Johansen, Berit T. Philbert, Sam Riahi, Christian Torp-Pedersen, Lars Kober, Jacob Tfelt-Hansen, Peter E. Weeke

Summary: This study aimed to investigate the association between a diagnosis of Brugada syndrome (BrS) and symptomatic disease presentation with new-onset depression or anxiety and all-cause mortality. The results showed that symptomatic BrS disease manifestation was significantly associated with new-onset depression or anxiety, while the overall mortality rate in these patients was low.

EUROPACE (2023)

Add to Collection

Editorial Material Cardiac & Cardiovascular Systems

Pre-discharge and early post-discharge management of patients hospitalized for acute heart failure: A scientific statement by the Heart Failure Association of the ESC

Marco Metra, Marianna Adamo, Daniela Tomasoni, Alexandre Mebazaa, Antoni Bayes-Genis, Magdy Abdelhamid, Stamatis Adamopoulos, Stefan D. Anker, Johann Bauersachs, Yuri Belenkov, Michael Boehm, Tuvia Ben Gal, Javed Butler, Alain Cohen-Solal, Gerasimos Filippatos, Finn Gustafsson, Loreena Hill, Tiny Jaarsma, Ewa A. Jankowska, Mitja Lainscak, Yuri Lopatin, Lars H. Lund, Theresa McDonagh, Davor Milicic, Brenda Moura, Wilfried Mullens, Massimo Piepoli, Marija Polovina, Piotr Ponikowski, Amina Rakisheva, Arsen Ristic, Gianluigi Savarese, Petar Seferovic, Rajan Sharma, Thomas Thum, Carlo G. Tocchetti, Sophie Van Linthout, Cristiana Vitale, Stephan Von Haehling, Maurizio Volterrani, Andrew J. S. Coats, Ovidiu Chioncel, Giuseppe Rosano

Summary: Acute heart failure is a common cause of urgent hospital admissions. Optimal management before and after discharge is critical to prevent rehospitalization and improve outcomes.

EUROPEAN JOURNAL OF HEART FAILURE (2023)

Add to Collection

Article Medicine, Research & Experimental

Investigating Generation of Antibodies against the Lipid Nanoparticle Vector Following COVID-19 Vaccination with an mRNA Vaccine

Rasmus Munter, Erik Sorensen, Rasmus B. Hasselbalch, Esben Christensen, Susanne D. Nielsen, Peter Garred, Sisse R. Ostrowski, Henning Bundgaard, Kasper K. Iversen, Thomas L. Andresen, Jannik B. Larsen

Summary: While concerns have been raised regarding the safety of lipid nanoparticles (LNPs) used in mRNA-based vaccines, a study found no significant increase in anti-LNP antibodies after vaccination with the Comirnaty COVID-19 vaccine. This is important in addressing concerns about potential allergic reactions and cross-reactions with other PEGylated therapeutics. The study suggests that LNPs used in the Comirnaty vaccine do not induce the production of anti-vector antibodies.

MOLECULAR PHARMACEUTICS (2023)

Add to Collection

Article Multidisciplinary Sciences

Diuretic treatment before and after transcatheter aortic valve implantation: A Danish nationwide study

Xenia Begun, Jawad Haider Butt, Soren Lund Kristensen, Peter Ejvin Weeke, Ole R. De Backer, Morten R. Schou, Lars R. Kober, Emil R. Loldrup Fosbol

Summary: This study examined the use of loop diuretics before and 1 year after transcatheter aortic valve implantation (TAVI) to assess changes in symptom severity and mortality risk.

PLOS ONE (2023)

Add to Collection

Article Medicine, General & Internal

Effect of a 12-week high-intensity exercise intervention: a comparison of cardiac exercise adaptations during biological disease-modifying antirheumatic drug treatment (TNF inhibitors vs IL-6 signalling inhibitors) in patients with rheumatoid arthritis - study protocol for a randomised controlled trial

Simon Jonck, Malte Lund Adamsen, Pil Hojgaard, Iben Elmerdahl Rasmussen, Helga Ellingsgaard, Morten Asp Vonsild Lund, Peter Godsk Jorgensen, Soren Jacobsen, Lars Kober, Niels Vejlstrup, Lene Dreyer, Bente Klarlund Pedersen, Ronan M. G. Berg, Regitse Hojgaard Christensen

Summary: The chronic inflammatory state in rheumatoid arthritis (RA) increases the risk of cardiovascular disease (CVD), with pro-inflammatory cytokines tumor necrosis factor (TNF) and interleukin 6 (IL-6) playing a vital role. Biological disease-modifying antirheumatic drugs (bDMARDs) may attenuate that risk. IL-6 is also a myokine, secreted from exercising skeletal muscles, where it exhibits anti-inflammatory effects that may mitigate the risk of CVD. We hypothesize that inhibiting IL-6 signaling will impair the cardiac and metabolic adaptations to exercise training compared to TNF inhibition in RA patients.

BMJ OPEN (2023)

Add to Collection

Article Cardiac & Cardiovascular Systems

Exercise-Induced Left Atrial Hypertension in Heart Failure With Preserved Ejection Fraction

Sheldon E. Litwin, Jan Komtebedde, Mo Hu, Daniel Burkhoff, Gerd Hasenfuss, Barry A. Borlaug, Scott D. Solomon, Michael R. Zile, Rajeev C. Mohan, Rami Khawash, Aaron L. Sverdlov, Peter Fail, Eugene S. Chung, David M. Kaye, John Blair, Jean-Christophe Eicher, Scott L. Hummel, Andreas Zirlik, Ralf Westenfeld, Christopher Hayward, Thomas M. Gorter, Catherine Demers, Ranjith Shetty, Gregory Lewis, Randall C. Starling, Sanjay Patel, Deepak K. Gupta, Hakim Morsli, Martin Penicka, Maja Cikes, Finn Gustafsson, Frank E. Silvestry, Ethan J. Rowin, Donald E. Cutlip, Martin B. Leon, Dalane W. Kitzman, Franz X. Kleber, Sanjiv J. Shah

Summary: This study aimed to characterize patients with exercise-induced left atrial hypertension. The study found that compared to patients with resting left atrial hypertension, these patients had lower natriuretic peptide levels, higher 6-minute walk distance, less atrial fibrillation, lower left ventricular mass, smaller LA volumes, lower E/e' values, and better LA strain.

JACC-HEART FAILURE (2023)

Add to Collection

Article Cardiac & Cardiovascular Systems

Associated rate of pacemaker implantation following transcatheter aortic valve implantation according to age: A nationwide study

Jeppe Kofoed Petersen, Emil Loldrup Fosbol, Kristian Kragholm, Christian Torp-Pedersen, Ole De Backer, Jarl Emanuel Strange, Lars Kober, Lauge Ostergaard

IJC HEART & VASCULATURE (2023)

Add to Collection

Article Cardiac & Cardiovascular Systems

Bundle branch block in cardiac arrest survivors without ischemic heart disease

Julie Terp Holm, Niels Kjaer Stampe, Priya Bhardwaj, Reza Jabbari, Finn Gustafsson, Niels Risum, Jacob Tfelt-Hansen, Bo Gregers Winkel

Summary: This study characterized cardiac arrest survivors with left/right bundle branch block (LBBB/RBBB) and no ischemic heart disease (IHD). The prevalence of LBBB among all CA survivors was high, and patients with LBBB had a significantly lower left ventricular ejection fraction (LVEF) compared to other types of BBB.

IJC HEART & VASCULATURE (2023)

Add to Collection

Article Infectious Diseases

Rifampicin reduces plasma concentration of linezolid in patients with infective endocarditis

Magnus Bock, Johan G. C. Van Hasselt, Franziska Schwartz, Hengzhuang Wang, Niels Hoiby, Kurt Fuursted, Nikolaj Ihlemann, Sabine Gill, Ulrik Christiansen, Niels Eske Bruun, Hanne Elming, Jonas A. Povlsen, Lars Kober, Dan E. Hofsten, Emil L. Fosbol, Mia M. Pries-Heje, Jens Jorgen Christensen, Flemming S. Rosenvinge, Christian Torp-Pedersen, Jannik Helweg-Larsen, Niels Tonder, Kasper Iversen, Henning Bundgaard, Claus Moser

Summary: This study characterized the population pharmacokinetics of linezolid in patients with infective endocarditis and found that there is a substantial interaction between linezolid and rifampicin, which increases the clearance of linezolid. Model-based simulations showed that increasing the linezolid dose can compensate for the interaction without increasing the risk of adverse effects.

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2023)

Add to Collection

Article Medicine, General & Internal

Humoral and cellular immune responses eleven months after the third dose of BNT162b2 an mRNA-based COVID-19 vaccine in people with HIV-a prospective observational cohort study

Line Dam Heftdal, Laura Perez-Alos, Rasmus Bo Hasselbalch, Cecilie Bo Hansen, Sebastian Rask Hamm, Dina Leth Moller, Mia Pries-Heje, Kamille Fogh, Jan Gerstoft, Kirsten Gronbaek, Sisse Rye Ostrowski, Ruth Frikke-Schmidt, Erik Sorensen, Linda Hilsted, Henning Bundgaard, Peter Garred, Kasper Iversen, Caroline Sabin, Susanne Dam Nielsen

Summary: This study investigated the long-term durability of humoral and cellular immune responses to the third dose of BNT162b2 in people with HIV and controls. The results showed that before the third dose, HIV patients had lower concentrations of SARS-CoV-2 antibodies compared to controls, but there were no differences in antibody concentrations between the two groups after four and eleven months of the third dose. Additionally, there were no differences in cellular immune response between the two groups four months after the third dose.

EBIOMEDICINE (2023)

Add to Collection

Article Cardiac & Cardiovascular Systems

Heart failure with preserved ejection fraction, red cell distribution width, and sacubitril/valsartan

Jawad H. Butt, Kirsty Mcdowell, Toru Kondo, Akshay S. Desai, Martin P. Lefkowitz, Milton Packer, Mark C. Petrie, Marc A. Pfeffer, Jean L. Rouleau, Muthiah Vaduganathan, Michael R. Zile, Pardeep S. Jhund, Lars Kober, Scott Solomon, John J. V. Mcmurray

Summary: Red cell distribution width (RDW) is a significant prognostic marker in patients with heart failure (HF) and reduced ejection fraction. However, its prognostic significance in HF with preserved ejection fraction is not well known. This study explored the relationship between RDW and outcomes, as well as the impact of sacubitril/valsartan compared with valsartan on RDW and clinical outcomes.

ESC HEART FAILURE (2023)

Add to Collection

Article Immunology

Humoral and T-cell response 12 months after the first BNT162b2 vaccination in solid organ transplant recipients and controls: Kinetics, associated factors, and role of SARS-CoV-2 infection

Omid Rezahosseini, Sebastian Rask Hamm, Line Dam Heftdal, Laura Perez-Alos, Dina Leth Moller, Michael Perch, Johannes Roth Madsen, Annemette Hald, Cecilie Bo Hansen, Jose Juan Almagro Armenteros, Mia Marie Pries-Heje, Rasmus Bo Hasselbalch, Kamille Fogh, Ruth Frikke-Schmidt, Linda Maria Hilsted, Erik Sorensen, Sisse Rye Ostrowski, Zitta Barrella Harboe, Kasper Iversen, Henning Bundgaard, Soren Schwartz Sorensen, Allan Rasmussen, Peter Garred, Susanne Dam Nielsen

Summary: We found that within 12 months after receiving at least three doses of the BNT162b2 vaccine, solid organ transplant (SOT) recipients had lower humoral and T-cell responses compared to controls, especially those without previous SARS-CoV-2 infection. However, SOT recipients with previous infection had comparable immune responses to controls.

FRONTIERS IN IMMUNOLOGY (2023)

Add to Collection

Article Surgery

Adherence to Pharmacotherapies After Heart Transplantation in Relation to Multimorbidity and Socioeconomic Position: A Nationwide Register-Based Study

Rikke E. Mols, Istvan Bakos, Brian B. Logstrup, Erzsebet Horvath-Puho, Finn Gustafsson, Hans Eiskjaer

Summary: This study examined the impact of multimorbidity and socioeconomic position on treatment patterns and adherence to pharmacological therapies in heart transplantation recipients. The study found that recipients with multiple chronic diseases had higher prevalence of treatment with antihypertensive pharmacotherapies and loop diuretics. Additionally, socioeconomically disadvantaged recipients had lower numbers of patients treated with and adherence to certain cost-free medications.

TRANSPLANT INTERNATIONAL (2023)

Add to Collection

No Data Available

© Peeref 2019-2024. All rights reserved.